We have previously cloned a type I serine/threonine kinase receptor from Xenopus, namely XTrR-I. We show here that XTrR-I is able to bind and mediate the activity of TGFb1, but is unable to mediate response to activin or BMP-4. We have made a truncated receptor construct that can act as a dominant negative mutant receptor, and this can block the activity of TGFb2 but not that of activin. Overexpression of either the full-length or truncated receptor has a drastic effect on mesoderm differentiation. The truncated receptor inhibits expression of notochord and muscle in mesodermalised animal caps, while the full-length receptor greatly increases the amount of notochord. In addition, the truncated receptor blocks the axis duplicating activity of both siamois and Xwnt8. We conclude that XTrR-I is involved in mediating a dorsalising activity important for mesoderm differentiation.
Introduction
Patterning of the amphibian embryo is promoted by two inductive interactions (reviewed in Slack, 1994) . The first of these involves the formation of the mesoderm, thought to occur via an interaction between the animal and vegetal pole regions of a blastula, first described by Nieuwkoop (1969) . Two classes of candidate molecules have been thought to play a role in mesoderm formation: these are the fibroblast growth factor (FGF) family, in particular bFGF (Slack et al., 1989) , and members of the transforming growth factor (TGFb) family, notably activin (Asashima et al., 1990; Smith et al., 1990) and Vg1 (Melton, 1987; Dale et al., 1993; Thomsen and Melton, 1993) . Differentiation of the mesoderm is influenced by a second set of inductive interactions, first suggested by the organiser graft experiments of Spemann and Mangold (1924) . Recent work has focused on these differentiation events and the identification of the molecules involved in this process.
A variety of studies have identified putative dorsalising factors expressed in the organiser region of the Xenopus embryo. These molecules were identified by different cloning strategies and have been shown to exhibit appropriate dorsalising activities and expression patterns. This class of genes includes noggin, siamois, chordin, and the Xenopus nodal related genes Xnr-1, -2 and -3 (Smith and Harland, 1992; Sasai et al., 1994; Jones et al., 1995; Lemaire et al., 1995; Smith et al., 1995) . Additional work has described a ventralising activity mediated by a TGFb factor, BMP-4 (reviewed in Hogan, 1996) . The ventralising activity of BMP-4 is thought to act during gastrulation and to attenuate dorsalising signals derived from the organiser (Jones et al., 1996) . It has recently been suggested that the role of the dorsalising factors noggin and chordin may be to bind directly to BMP-4, and so inactivate its ventralising activity (Holley et al., 1996; Piccolo et al., 1996; Zimmerman et al., 1996) . Therefore mesoderm differentiation may be controlled by a number of secreted molecules with antagonising activities.
While the molecular mechanisms of mesoderm formation and differentiation have not been fully elucidated, it is known that members of the TGFb family play an important role. Signal transduction by members of the TGFb family is mediated by transmembrane serine/threonine kinase receptors (reviewed in Kingsley, 1994; Massagué et al., 1994) . Signalling is achieved via a heteromeric complex containing two classes of transmembrane serine/threonine kinases called type I and type II receptors (Wrana et al., 1992) . Type I and type II receptors have been cloned from a number of organisms and have been shown to have different ligand specificities (Massagué, 1996) . In Xenopus there have been reports describing receptors for both activin and BMP-4 (Kondo et al., 1991; Mathews et al., 1992; Graff et al., 1994; Maeno et al., 1994) . Further experiments using dominant negative mutants of these receptors have helped to analyse the roles of both activin and BMP-4 in normal development (Hemmati-Brivanlou and Melton, 1992; Graff et al., 1994; Maeno et al., 1994) . We have previously described the cloning of a novel type I serine/threonine kinase receptor, that is able to cause dorsalisation of mesoderm (Mahony and Gurdon, 1995) . Here we have further characterised the XTrR-I receptor, and show that it can act as a receptor for TGFb1 but not for activin or BMP-4. We have also constructed a truncated form of the XTrR-I receptor, that acts as a dominant negative mutant receptor, and show that overexpression of the full-length and truncated forms of XTrR-I have opposite effects on mesoderm differentiation. We therefore conclude that XTrR-I may be important in the signalling events required for mesoderm differentiation.
Results

A truncated form of XTrR-I, Dom 5, blocks induction of mesoderm by TGFb2
Previous work has described the use of truncated receptor constructs that behave as dominant negative mutants and block the activity of endogenous wild type receptors. Such mutants have been important in examining the role of bFGF, activin and BMP 4 (Amaya et al., 1991; Hemmati-Brivanlou and Melton, 1992; Graff et al., 1994; Maeno et al., 1994) We have therefore followed a similar strategy to further analyse the role for the XTrR-I receptor and have made a C-terminal deletion construct, Dom 5, that lacks the intracellular serine/threonine kinase domain of the wild-type receptor. Mutant receptors of this kind interact with wild-type receptors to form complexes that can bind ligand but are unable to exercise intracellular signalling. To demonstrate the function and to determine the specificity of this mutant, we have used an assay in which a blastula animal cap containing in-vitro transcribed Dom 5 mRNA is incubated in the presence of known mesoderm-inducing proteins. After a few hours the animal caps were assayed for expression of X-brachyury (Xbra), a mesodermal marker which is normally induced in animal caps by these mesoderm inducing factors . An inhibition of the usual effect of mesoderm-inducing protein would suggest a class of ligand for the receptor and a possible role in mesoderm formation.
Xenopus mesoderm inducing factors fall into two groups, namely those belonging to the FGF and TGFb families of growth factors. Therefore we first tested representatives of these two families, bFGF and TGFb2. We postulated that the truncated XTrR-I receptor would interfere with TGFb signalling which is mediated by serine/threonine kinase receptors, but not with the bFGF pathway which acts through a tyrosine kinase receptor. Indeed, we found that Xbra induction by bFGF is totally unaffected by the truncated receptor, whereas induction by TGFb2 was completely inhibited. In Fig. 1A , Xbra synthesis by animal caps incubated in bFGF was at about the same high level whether the caps contain the Dom 5 mRNA or not (tracks 3 and 4). Xbra was strongly induced by TGFb2 in animal caps that contain no injected mRNA (track 6), but not at all in the animal caps that contained Dom 5 mRNA (track 5). These results, compared to controls (tracks 1 and 2), are consistent with the expectation that the receptor is involved in TGFb but not bFGF signalling.
This led us to ask whether the truncated receptor shows any specificity within the TGFb family. To test this we compared the induction of Xbra by TGFb2 with that by XTC-MIF, the major constituent of which is activin (Smith et al., 1990) . We found the animal caps injected with Dom 5 mRNA and incubated in XTC-MIF show strong expression of Xbra (Fig. 1B, tracks 3 and 4) , even though in a parallel experiment TGFb2 signalling was blocked as before (Fig. 1B , tracks 5 and 6). Therefore the truncated receptor Dom 5 is able to block the action of TGFb2 but not that of activin in this assay. These results show that the truncated receptor is functional in the animal cap assay used and that it is able to discriminate between different members of the TGFb family of growth factors.
XTrR-I can act as a receptor for TGFb but not for activin or BMP-4
Since the truncated receptor is able to block the action of TGFb2 in the animal cap assays, we assessed the ability of XTrR-I to act as a type I receptor for TGFb family members in a different system. Previous work has described the R-1B/ L17 mutant cell line that does not express endogenous type I receptors (Boyd and Massagué, 1989; Laiho et al., 1990) . In a first series of experiments we tested the ability of XTrR-I transfection to confer responsiveness to TGFb1 activin A or BMP-4 in R-IB/L17 cells. It has previously been demonstrated that transfection of a human TGFb type I receptor, TbR-I, into these cells restores responsiveness to TGFb, as measured by its ability to induce expression of the 3TP-lux reporter gene or to induce cell cycle arrest (Franzen et al., 1993; Bassing et al., 1994; Carcamo et al., 1994) . Previous work has also shown that transfection of the activin type I receptor ActR-IB into these cells confers the ability to induce expression of the reporter gene in response to activin A (but not to TGFb) (Carcamo et al., 1994) . In addition. cotransfection of the BMP type II receptor BMPR-II together with the BMP/activin type I receptor ActR-IA confers the ability to generate a small (3-4 fold) induction of 3TP-lux by BMP-4 (Liu et al., 1995) .
We first assessed the ability of XTrR-I to confer TGFb responsiveness in R1B/L17 cells. XTrR-I, TbR-I and a kinase defective mutant (KR) of TbR-I (used as a negative control) were transfected side-by-side using three different amounts of plasmid DNA (20, 200 and 2000 ng) in each case. Each of these nine separate transfections was incubated with either 0, 2.5, 25 or 250 pM TGFb1, and the activity of a contransfected 3TP-luciferase construct was assayed in triplicate. Fig. 2A shows that 200 ng of XTrR-I vector was as effective as 20 ng of TbR-I vector in conferring responsiveness to TGFb. In both cases the maximal response was about a 50-fold induction of luciferase relative to the negative (KR) control, and was achieved with 25 pM TGFb1. These results show that XTrR-I can mediate a TGFb response, presumably in concert with an endogenous type II receptor, most likely TbR-II. However on a plasmid DNA concentration basis, the XTrR-I vector was at least ten times less potent than the TbRI vector. This could be due to a lower expression level of XTrR-1 or a lower activity of XTrR-I as a TGFb1 receptor.
In a similar design of experiment, XTrR-I was compared to ActR-IB to assay the relative abilities of these receptors to mediate a response to activin A. Three different amounts of plasmid DNA (20, 200 and 2000 ng) were transfected into R-1B/L17 cells Each of these separate transfections was incubated with 0, 50, 500 or 5000 pM activin A and the activity of the 3TP-luciferase construct was measured.
Transfection of 20 ng of ActR-IB was sufficient to confer responsiveness to activin (Fig. 2B ), but even transfection of 2000 ng of XTrR-I could not elicit a response in this experiment. In a more limited experiment, transfection of BMPR-II with ActR-IA conferred responsiveness to BMP 4 (Fig.  2C) ; however cotransfection of XTrR-I with BMPR-II was unable to elicit any response. Therefore XTrR-I is unable to mediate the response to either activin or BMP-4, and so is unlikely to be an effective receptor for either of these ligands.
In a second series of experiments, we directly tested the ability of XTrR-I to interact with TGFb1 in a ligand-receptor crosslinking assay. R-1B/L17 cells were transfected with vector alone (pCMV5), TbR-I or XTrR-1. The transfectants were then incubated with 0.1 nM radiolabelled TGFb1, alone or in the presence of an excess of unlabelled TGFb1, as a specific competitor. Cells were then crosslinked to bound ligand by incubation with disuccinimidyl suberate. As expected, R-1B/L17 cells transfected with vector alone showed labelling of endogenous TbR-II but not of TbR-I (Fig. 3, lane 7) , and cells transfected with TbR-I showed labelling of this receptor and TbR-II (Fig. 3, lane Fig. 2. XTrR-I can mediate a TGFb response but not activin or BMP responses. R1B/L17 cells were transfected with the indicated amounts of vector DNA encoding the type I receptors (A,B) or type I receptors plus BMPR-II (C), together with the reporter construe p3TP-lux. Cells were incubated for 24 h with the indicated concentrations of growth factor, and luciferase activity was determined in triplicate samples. In all cases, SD was less than 10% of the value shown. 1). Cells transfected with XTrR-I showed labelling of a band corresponding to the size of XTrR-I (Fig. 3, lane 4) . This labelling was specifically competed by TGFb (Fig. 3 , lanes 5 and 6). Labelling of XTrR-I was less intense than labelling of TbR-I. This could be due to a lower expression of XTrR-I, a lower affinity of XTrR-I for TGFb1, a lower efficiency of the crosslinking reaction (which requires lysines in the extracellular domain of the receptor), or a combination of these factors. Therefore, since we have shown that XTrR-I can confer TGFb responsiveness and bind TGFb1 in a ligand binding assay, we conclude that XTrR-I can act as a type I receptor for TGFb1.
Dom 5 inhibits the induction of notochord and muscle in animal caps
Our previous work suggested that XTrR-I is involved in the dorsalisation of mesoderm. We might therefore expect the truncated receptor to inhibit the differentiation of mesoderm into dorsal cell types such as muscle and notochord. It is important to appreciate that the initial formation of mesoderm and its subsequent differentiation into specialised cell types involve different processes. Mesoderm formation, of which Xbra is an early molecular marker, is complete by the end of the gastrula stage when animal caps lose their ability to respond to mesoderm inducers such as activin (Jones and Woodland, 1987) . The subsequent conversion of mesoderm into muscle and notochord, namely mesoderm differentiation, takes place during gastrulation and can be induced by noggin (Smith and Harland, 1992) and nodal related factors (Jones et al., 1995; Smith et al., 1995) but not by activin Lettice and Slack, 1993) . In addition, further studies, using activin induction of isolated cells, suggest that cell-cell communication is important for terminal mesoderm gene expression, and this may be mediated by a growth factor signalling pathway downstream of activin (Green et al., 1994; Wilson and Melton, 1994) . The mechanism of this differentiation process is not known, but may involve the combination of a dorsalising signal emanating from the organiser region and further local signalling events, including a community effect, to generate homogeneous populations of differentiated cells .
We have already shown that neither XTrR-I nor the truncated receptor is able to modulate the effects of activin. Therefore we decided to use activin as an initial mesoderm-forming inducer of animal caps in which subsequent signalling processes must take place in order for them to form muscle and notochord. We can then assess the effect of overexpression of XTrR-I or Dom 5 on these later signalling processes by assaying the amount of muscle or notochord formed. For these experiments we injected activin mRNA into two-cell eggs, instead of incubating animal caps in solutions containing activin protein since we obtain stronger inductions by message injection. In order to analyse the effect of XTrR-I and Dom 5 overexpression on the type of mesoderm formed, we co-injected activin mRNA with either full-length XTrR-I or with Dom 5 mRNA. Two-cell embryos were injected at the animal pole with mRNAs, and cultured to stage 8, when their animal caps were removed and cultured until fixation at the equivalent of stage 28. They were then stained with markers for muscle (12/101) or notochord (MZ15) to assess the amount of mesoderm differentiation.
Since this experimental system is somewhat different from that used in the earlier section, we first showed that the induction of Xbra by injection of activin mRNA into the animal pole, i.e. mesoderm formation, is not affected by the co-injection of either the dominant negative or full-length receptor mRNAs (Fig. 4) . This recapitulates the result we obtained before and shows that the effect of the injection of message gives similar results to treatment with a protein growth factor. More importantly, it shows that the amount of mesoderm formed in each of these samples, as assayed by Xbra expression, is unaffected by injection of full-length or truncated XTrR-I receptor mRNAs. Animal caps that have been injected with activin mRNA alone subsequently show substantial amount of muscle tissue (black) and a significant amount of notochord (red) as assayed by antibody staining (Fig. 5A and Table 1 ). Since we know that overexpression of XTrR-I can cause or enhance the expression of dorsal markers in normal embryos, we co-injected activin message with the XTrR-I mRNA into animal caps to see if we could observe a similar effect. When the full-length XTrR-I mRNA is co-injected with activin message, there is a significant increase in the amount of notochord staining in 65% of samples ( Fig. 5B and Table 1 ). There is also an apparent decrease in muscle marker expression, probably because most of the induced mesoderm tissue is now notochord Therefore, XTrR-I mRNA overexpression is able to promote mesoderm differentiation. We then co-injected the activin message with mRNA from Dom 5. When the truncated receptor mRNA is co-injected with activin message over 98% of the caps stained show no notochord staining and 48% show no muscle staining (Fig. 5C and Table 1 ). Of those that show some muscle staining, it is generally much less than that seen in activin message injected caps alone. If both XTrR-I and Dom 5 mRNAs are co-injected with activin then the phenotype is similar to injection of activin message alone (data not shown). Therefore, overexpression of full-length XTrR-I greatly enhances the differentiation of mesoderm formed by activin, while overexpression of Dom 5 greatly reduces the amount of dorsal mesoderm induced by activin. These data are consistent with the earlier findings, above that show that XTrR-I and Dom 5 do not modulate the early effects of activin.
The inhibition of dorsal mesoderm by Dom 5 raises the question whether this effect is paralleled by the enhanced differentiation of ventral mesoderm. To investigate this, we prepared animal caps injected with activin and Dom 5, or activin and XTrR-l, mRNAs and assayed these for dorsal gene expression using chordin as a marker (Sasai et al., 1994) , and for ventral gene expression, using Xvent-1 and Xvent-2 as markers (Gawantka et al., 1995; Onichtchouk et al., 1996) . Using RT-PCR analysis with subsequent phosphorimager quantitation, we found a 2-9 fold enhanced expression of Xvent-1 and -2 by comparison with the dorsalising effect of chordin. The animal caps were analysed at stage 16, as is appropriate for this set of markers, whereas the muscle and notochord antibody assays (above) were carried out on material at stage 28.
We conclude that the overexpression of XTrR-1 or Dom 5 affects a step or steps after the formation of mesoderm as measured by the expression of Xbra, and during the differentiation of mesoderm as assayed by the expression of later muscle or notochord specific genes. This suggests that XTrR-I is a receptor for a ligand that works downstream of activin, and that this ligand may be important for the signalling processes required for mesoderm differentiation.
Dom 5 is able to block axis formation in the embryo
Since the truncated receptor has a striking effect on the dorsalising activity of activin, we have analysed the effect of the truncated receptor on axis-formation in the whole embryo. We injected Dom 5 mRNA into the equatorial region of eggs, that is in the region of prospective mesoderm, and cultured the embryos to free-swimming tadpole stages (stage 40). None of these injection experiments gave a consistent phenotype (data not shown) and in many cases there were gastrulation defects. We consider it very hard to interpret such abnormalities which can arise for many rea- sons; disturbances of the early mesoderm can have diverse consequences because of its importance in secondary inductions. We therefore decided to use a more amenable strategy by utilising mRNAs that are able to initiate the formation of an ectopic secondary axis. Previous studies have identified some genes that are able to induce a secondary axis when their mRNA is injected into the ventral side of a two-cell embryo. It has been suggested that this secondary axis formation is mediated by causing an ectopic Spemann organiser on the ventral side of the embryo. Two of the most effective secondary axis inducing molecules are Xwnt8 and siamois which consistently give complete secondary axes (Smith and Harland, 1991; Sokol et al., 1991; Lemaire et al., 1995) . We therefore investigated whether Dom 5 could inhibit the formation of a secondary axis induced by either Xwnt8 or siamois. Fig. 6A shows the effect of injecting 10 pg of siamois mRNA into the ventral side of a four-cell embryo. Seventyfive of these embryos form a secondary axis ( Fig. 6A and Table 2 ) and all of these are complete secondary axes, which we score by the presence of a cement gland, an anterior-dorsal structure, in the secondary axis. When Dom 5 is co-injected with siamois then none of the embryos form a complete secondary axis; moreover all axis-forming activity seems to be inhibited since none of the embryos have even an incomplete axis duplication ( Fig. 6B and Table 2 ). Similarly, when 5 pg of Xwnt8 mRNA is injected on the ventral side of an embryo, 95% of embryos have complete secondary axes (Fig. 6C and Table 2 ). With co-injection of Dom 5 and Xwnt8, only 12% of embryos have complete secondary axes, 24% display incomplete secondary axes and 64% of embryos only have a single axis ( Fig. 6D and Table 2 ). Therefore the truncated form of XTrR-I is very efficient at blocking induced axis formation.
Discussion
Recent work has described a number of secreted factors that appear to play a role in the normal dorsal-ventral patterning of the Xenopus embryo (Smith and Harland, 1992; Sasai et al., 1994; Jones et al., 1995 Jones et al., , 1996 Moos et al., 1995; Smith et al., 1995) . However, the molecular events by which these secreted factors cause such differentiation events is not well understood. The present study suggests that XTrR-I is involved in such a signalling mechanism, and is able to direct the differentiation of mesoderm to dorsal fates.
The ligand binding experiments show that XTrR-I can act as a receptor for TGFb1 and can also display some ligand specificity. It has been previously suggested that some type I receptors may interact with more than one type II receptor, and so be able to mediate signals from a number of TGFb superfamily ligands (reviewed in Massagué et al., 1994) . Our experiments show that XTrR-I is unable to mediate the effects of either activin or BMP-4. Therefore the physiological ligands for XTrR-I might include the TGFb isoforms described for Xenopus (Rosa et al., 1988) or members of the TGFb superfamily other than activin or BMP-4. The role of the Xenopus TGFb isoforms in the normal development of the embryo has not been fully described. However, one report suggests that TGFb1 is able to synergise with bFGF in animal cap assays, so as to give an increased expression of muscle actin expression compared to bFGF treatment alone (Kimelman and Kirschner, 1987) . Whether TGFb1 actually plays such a role in vivo is not known. More recent work has described three Xenopus homologues of the mouse nodal gene, which was identified as a TGFblike gene expressed in the mouse node during gastrulation (Zhou et al., 1993; Jones et al., 1995; Smith et al., 1995) . All three of these growth factors, Xnr-1, Xnr-2 and Xnr-3, are able to cause dorsalisation of ventral marginal zones. However, both Xnr-I and Xnr-2, unlike XTrR-I, are able to induce mesoderm formation when injected into animal caps, and are not therefore candidate ligands for XTrR-I. To test whether Xnr-3 behaves as an XTrR-I ligand, we have asked whether the XTrR-I mutant Dom 5 counteracts the biological activity of Xnr-3. The injection of Xnr-3 mRNA into the animal pole of two-cell embryos induced prominent protrusions exactly as described previously , as also did Xnr-3 mRNA co-injected with Dom 5 mRNA (data not shown). This preliminary test suggests that Xnr-3 does not behave as a ligand for XTrR-I.
Using an animal cap induction assay system we have shown that Dom 5 can block the activity of TGFb2, but not the activity of bFGF or activin. This correlates with the ligand binding data, and shows that neither the fulllength nor the truncated receptor is able to modulate the early effects of activin. Induction of mesoderm by activin is thought to occur in two stages, a mesoderm formation step followed by a mesoderm differentiation step. The dorsalventral patterning of the mesoderm initiated by activin is significantly altered by both types of receptor, such that overexpression of XTrR-I gives an increase in dorsal tissues and overexpression of Dom 5 results in a depletion in the amount of dorsal tissue, so that there is virtually no detectable notochord tissue and a significant decrease in muscle tissue. This confirms that patterning of the mesoderm initiated by activin is completed by downstream growth factor signalling pathways, and that such signalling pathways are mediated through the XTrR-I receptor. Moreover, Dom 5 is able to block axis formation by two previously described axis forming genes, Xwnt8 and siamois. It is not apparent to what extent these two genes mimic the endogenous axis forming activities, but they are both capable of forming complete secondary axes when injected into the ventral side of a four-cell stage embryo. Dom 5 is able to completely block this axis forming activity, suggesting a function for XTrR-I in this axis forming mechanism which includes mesoderm differentiation.
Therefore XTrR-I can act as a receptor for TGFb, although it is quite possible that other ligands may be impor-tant in vivo. XTrR-I certainly appears to be able to transduce signals that can cause differentiation of the mesoderm. In addition, blocking this signalling pathway with a truncated receptor construct can severely reduce the amount of dorsal tissue or secondary axis formation initiated by previously described genes. Recent work concerning the dorsal-ventral patterning of the mesoderm has emphasised the importance of regulating the ventralising activity of BMP-4 (De Robertis and . It has been shown that both chordin and noggin, dorsalising molecules expressed in the organiser, are able to bind directly to BMP4 and so possibly antagonise its ventralising activity (Holley et al., 1996; Piccolo et al., 1996; Zimmerman et al., 1996) . While this may be an important mechanism for regulating the potent ventralising activity of BMP4, our results suggest that mesoderm differentiation is not solely dependent upon directly inactivating BMP4. The overexpression of full-length and truncated receptors have opposite effects on mesoderm differentiation, and so strongly suggest that XTrR-I mediates a direct dorsalising signal. Therefore we conclude that XTrR-I is likely to be involved in a signalling cascade that leads to mesoderm differentiation and so to correct patterning of the embryo.
Experimental procedures
Embryo manipulations and mRNA microinjection
Eggs were fertilised in vitro, dejellied and cultivated as previously described . For microinjection, embryos were transferred to 4% Ficoll-400 (Pharmacia) in l× MBS, and 4.6 nl or 9.2 nl of mRNA solution injected using a Drummond Nanoject microinjector. Synthetic capped mRNA was prepared using the T3 and Sp6 Ambion Megascript in vitro Transcription Kits.
Construction of dominant negative mutant construct
A dominant negative mutant construct was made by amplifying the region encoding the first 202 amino acids of XTrR-I (Mahony and Gurdon, 1995) by PCR amplification. Two rounds of PCR amplification were used. In order to generate a myc tag at the 3′ end of the clone, the 5′ primer, DOM 51, was the same for both rounds and the primers DOM 31, used in the first, and DOM 32, in the second, rounds of amplification. DOM 51 was a 32-mer oligonucleotide (5′-CCCTCTCCATGGCTGTATCGG-CTTCTTATCTG-3′), primer DOM 31 a 45-mer oligonucleotide (5′CCTCCTCAGAAATCAGCTTTTGCTCTTG CT-CAATTGTTCTTTGCACAAGTA-3′) and primer DOM 32 a 43-mer oligonucleotide (5′GAGGGTTA-CCTCAT-GGGAACAGATCCTCCTCAGAAATCAG-CT T-3′). The cycling parameters were the same for both rounds of amplification, namely 94°C for 30 s, 37°C for 30 s, 72°C for 1 min for the first three cycles, then 94°C for 30 s, 55°C for 30 s, 72°C for 1 min, for a further 24 cycles, followed by 72°C for 10 min. The PCR product was purified as described above, and cloned into the pSP64-Xbm vector (Krieg and Melton, 1984) .
RNase protection assays
These assays were performed as previously described (Lemaire and Gurdon, 1994) . The FGF receptor and Xbra probes were those used by Lemaire and Gurdon (1994) . The actin probe was as described by Gurdon et al. (1985) .
Cell transfections and TGFb functional assays
R1B/L17 cells were transfected with vectors encoding the indicated receptor, and the response of the 3TP-luciferase reporter construct to TGFb1, activin or BMP4 was determined as previously described (Carcamo et al., 1994; Chen et al., 1997) .
Receptor affinity labelling
R1B/L17 cells were transiently transfected with vectors encoding TbR-I, XTrR-I or empty vector by the DEAEdextran method under conditions in which half of the cell population takes up plasmid DNA (Carcamo et al., 1994; Wrana et al., 1994) . Two days after transfection, cells were affinity-labelled with [ 125 I]TGFb1 as previously described (Massagué, 1987; Cheifetz et al., 1990) . Briefly, cells were preincubated at 37°C in Krebs Ringer HEPES (KRH) buffer containing 0.5% bovine serum albumin (BSA), washed with cold KRH/0.5% BSA, and incubated with 100 pM [ 125 I]TGFb1 alone or with unlabelled TGFB1 in KRH/ 0.5% BSA for 3.5 h at 4°C. Then, the cells were washed four times in ice-cold KRH containing 0.5% BSA and once more with KRH alone. Subsequently, receptors were crosslinked to bound [ 125 I]TGFb1 by incubation for 15 min at 4°C with 60 mg/ml of disuccinimidyl suberate in KRH: crosslinking was terminated by washing cells twice with an icecold solution containing 0.25 M sucrose, 10 mM Tris-HCl (pH 7.4) and 1 mM EDTA. Cells were then lysed in a solution containing 20 mM Tris-HCl (pH 7.4), l50 mM NaCl, 1% Triton X-100 (v./v.) and protease and phosphatase inhibitors, and the cell lysate subjected to sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and autoradiography.
Antibody staining of Xenopus embryos
Embryo fixation and antibody staining were performed as previously described . Muscle staining was carried out with the 12/101 antibody (Kintner and Brockes, 1984) and notochord using the MZ15 antibody (Smith and Watt, 1985) . For double-staining of animal cap tissue, 12/101 staining was carried out as normal. Slides were kept overnight in PBS-Tween 20/EDTA at 4°C and then MZ15 staining completed using the Vector substrate kit I.
Animal cap assay
Animal Cap assays were carried out as described by Dawid (1991) . Recombinant human TGFb2 (Genzyme) and recombinant human bFGF (R and D Systems) were both used at concentration of 40 ng/ml in these assays. XTC-MIF (gift of J. Heasman) was used undiluted. Animal caps were dissected at stage 8.5 and cultured in the appropriate growth factor medium until stage 10.5. RNA was then prepared from these samples as has been described previously (Lemaire and Gurdon, 1994) .
